| Ellen Christine Redling, RN,CS,MS | |
|
44355 Premier Plz, Suite 120, Ashburn, VA 20147-5049 | |
| (703) 955-0537 | |
| (703) 723-5998 |
| Full Name | Ellen Christine Redling |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 44355 Premier Plz, Ashburn, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366448029 | NPI | - | NPPES |
| 355608 | Other | VA | MAMSI |
| 256426 | Other | VA | ANTHEM BC/BS |
| 55-1060-1 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 0015000549 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Christine Redling, RN,CS,MS 47168 Sky Ln, Sterling, VA 20165-7515 Ph: (703) 444-5059 | Ellen Christine Redling, RN,CS,MS 44355 Premier Plz, Suite 120, Ashburn, VA 20147-5049 Ph: (703) 955-0537 |
News Archive
AIDS Healthcare Foundation (AHF), the nation's largest HIV/AIDS nonprofit medical provider, today expressed its disappointment and dismay at the Food and Drug Administration's (FDA) decision to grant an expedited review for Gilead Sciences' application for expanded use of its blockbuster AIDS drug, Truvada, as a means of preventing HIV infection in non-infected people.
Health Canada is informing Canadians that multiple distributors (Positive Health, dailySupply, BestDealCA, eshopic, Urban Inspirations, grabthesale, and dealkings) are selling the unlicensed "OraQuick in Home HIV Test" kit via Amazon.ca.
In what is believed to be the largest follow-up record of patients with the most common form of hereditary dystonia - a movement disorder that can cause crippling muscle contractions - experts in deep brain stimulation report good success rates and lasting benefits.
New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.
› Verified 3 days ago
Billinda Tebbenhoff, NP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 20329 Advantage Ct, Ashburn, VA 20147 Phone: 703-395-2936 |